August 2026
1. SIEGAL DM, Carrier M, Bahit MC, Bosch J, et al
   Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A COMBINE-AF Analysis.
   Circulation. 2026 Aug 4. doi: 10.1161/CIRCULATIONAHA.125.079205.
   

   >> Share

   
   
2. JOYNT MADDOX KE, Reynolds HR, Adedinsewo D, Bushnell C, et al
   Correction to: Forecasting the Burden of Cardiovascular Disease and Stroke in Women in the United States through 2050: A Scientific Statement from the American Heart Association.
   Circulation. 2026;154:e233-e234.
   

   >> Share

   
   
3. PALANIAPPAN LP, Allen NB, Almarzooq ZI, Anderson CAM, et al
   Correction to: 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
   Circulation. 2026;154:e231-e232.
   

   >> Share

   
   July 2026
4. GANESH A, Sujanthan S, Muir RT, Joundi RA, et al
   Major Adverse Cognitive Events (MACE-Cog): A New "MACE" Framework for Cognitive Outcomes in Cardiovascular Diseases and Stroke.
   Circulation. 2026;154:378-394.
   

   >> Share

   
   June 2026
5. SANDOVICI M, van der Geest KSM, Reitsema RD, Dhaun N, et al
   Challenges and Future Trends in Large Vessel Vasculitis.
   Circulation. 2026;153:2064-2083.
   

   >> Share

   
   May 2026
6. HAN F, Clancy U, Arteaga-Reyes C, Thrippleton MJ, et al
   Implications of Cranial Arterial Stenosis and Dolichoectasia for Cerebral Small-Vessel Disease Etiopathogenesis: Findings From a Prospective Mild Stroke Cohort.
   Circulation. 2026 May 6. doi: 10.1161/CIRCULATIONAHA.126.079493.
   

   >> Share

   
   April 2026
7. SARFO FS, Akpalu A, Bockarie AS, Nguah SB, et al
   Phone-Based Intervention Under Nurse Guidance for Control of Hypertension After Stroke: A Randomized Multicenter Phase 3 Trial in Ghana.
   Circulation. 2026 Apr 9. doi: 10.1161/CIRCULATIONAHA.125.077424.
   

   >> Share

   
   
8. STEPANIAN A, Jaffe IZ
   Response by Stepanian and Jaffe to Letters Regarding Article, "Ponatinib, but Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Inf
   Circulation. 2026;153:e1113-e1114.
   

   >> Share

   
   
9. ZHENG T, Yuan X, Liu H
   Letter by Zheng et al Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
   Circulation. 2026;153:e1109-e1110.
   

   >> Share

   
   
10. XU X, Zhang S, Bao L
    Letter by Xu et al Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
    Circulation. 2026;153:e1111-e1112.
    

    >> Share

    
    
11. LIU C, Li X
    Letter by Liu and Li Regarding Article, "Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke".
    Circulation. 2026;153:e1107-e1108.
    

    >> Share

    
    March 2026
12. VEMULAPALLI S, Pena Guerra K, Wojdyla D, Jones WS, et al
    Adaptive AI for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the ODYSSEY OUTCOMES and EUCLID Trials.
    Circulation. 2026 Mar 30. doi: 10.1161/CIRCULATIONAHA.126.080072.
    

    >> Share

    
    
13. KHAN F, Yogendrakumar V, Lun R, Marx CE, et al
    Prognostic Factors for Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-Analysis.
    Circulation. 2026 Mar 18. doi: 10.1161/CIRCULATIONAHA.125.078763.
    

    >> Share

    
    February 2026
14. JOYNT MADDOX KE, Reynolds HR, Adedinsewo D, Bushnell C, et al
    Forecasting the Burden of Cardiovascular Disease and Stroke in Women in the United States Through 2050: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Feb 25. doi: 10.1161/CIR.0000000000001406.
    

    >> Share

    
    
15. ZHAO L, Zhao C, Wang Y
    Letter by Zhao et al Regarding Article, "Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study".
    Circulation. 2026;153:e71-e72.
    

    >> Share

    
    
16. HUANG Q, Jian X, Wu F
    Letter by Huang et al Regarding Article, "Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study".
    Circulation. 2026;153:e69-e70.
    

    >> Share

    
    
17. GONG CX, Shi PX, Huang YJ, Dai Y, et al
    Apolipoprotein D, a Novel Ligand for CD36, Is Essential for Blood-Brain Barrier Integrity.
    Circulation. 2026 Feb 6. doi: 10.1161/CIRCULATIONAHA.125.077356.
    

    >> Share

    
    January 2026
18. PALANIAPPAN LP, Allen NB, Almarzooq ZI, Anderson CAM, et al
    2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
    Circulation. 2026 Jan 21. doi: 10.1161/CIR.0000000000001412.
    

    >> Share

    
    December 2025
19. WANG X, Liu H, Lu Q
    A Storm of Tachycardia Following Stroke: What Is the Mechanism?
    Circulation. 2025;152:1732-1734.
    

    >> Share

    
    November 2025
20. HO JK, Hankey GJ
    Unsuccessful Thrombectomy During Acute Ischemic Stroke: Can it be Rescued by Angioplasty or Stenting?
    Circulation. 2025;152:1408-1410.
    

    >> Share

    
    
21. YIN X, Huang L, Tian M, Song H, et al
    Risks of Hyperkalemia With Potassium-Enriched Salt Substitute Among Patients Using Concomitant Blockade of the Renin-Angiotensin-Aldosterone System in the Salt Substitute and Stroke Study.
    Circulation. 2025;152:1311-1313.
    

    >> Share

    
    
22. MONGUILLON V, Kelly P, O'Donoghue ML, Park JG, et al
    Efficacy and Safety of Very Low Achieved LDL-Cholesterol in Patients with Prior Ischemic Stroke.
    Circulation. 2025 Nov 3. doi: 10.1161/CIRCULATIONAHA.125.077549.
    

    >> Share

    
    October 2025
23. YANG H, Zhong Y, Guo W, Guo W, et al
    TAX1BP3 Is a SUMOylated Nucleocytoplasmic Shuttling Protein and Protects Against Vascular Neointimal Hyperplasia.
    Circulation. 2025;152:1087-1108.
    

    >> Share

    
    September 2025
24. ZHU Z, Wu L, Chen M
    Letter by Zhu et al Regarding Article, "Disparities in Emergency Medical Services Use, Prehospital Notification, and Symptom Onset to Arrival in Patients With Acute Stroke".
    Circulation. 2025;152:e110-e111.
    

    >> Share

    
    
25. STAMM B, Royan R, Madsen TE
    Response by Stamm et al to Letter Regarding Article, "Disparities in Emergency Medical Services Use, Prehospital Notification, and Symptom Onset to Arrival in Patients With Acute Stroke".
    Circulation. 2025;152:e112-e113.
    

    >> Share

    
    August 2025
26. OLDGREN J, Hijazi Z, Arheden H, Bjorkenheim A, et al
    Biomarker-based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation - a Registry-based Multicenter Randomized Controlled Study.
    Circulation. 2025 Aug 30. doi: 10.1161/CIRCULATIONAHA.125.076725.
    

    >> Share

    
    
27. KENNEDY J, Blackman DJ, Dodd M, Poggesi A, et al
    Impact of Cerebral Embolic Protection On Cognitive Function Following Transcatheter Aortic Valve Implantation: Data From the BHF PROTECT-TAVI Randomized Trial.
    Circulation. 2025 Aug 30. doi: 10.1161/CIRCULATIONAHA.125.076761.
    

    >> Share

    
    
28. GIACOPPO D, Alvarez-Covarrubias H, Xhepa E, Matsuda Y, et al
    Transcatheter Aortic Valve Replacement With Balloon- Versus Self-Expandable Bioprostheses for the Treatment of Bicuspid Aortic Valve Stenosis.
    Circulation. 2025 Aug 18. doi: 10.1161/CIRCULATIONAHA.124.069323.
    

    >> Share

    
    
29. LAWN RB, Murchland AR, Thurston RC, Marquez C, et al
    Experiences of Stalking and Obtaining a Restraining Order Are Associated With Onset of Cardiovascular Events in Women: A Prospective Analysis in the Nurses' Health Study II.
    Circulation. 2025 Aug 11:10.1161/CIRCULATIONAHA.124.073592.
    

    >> Share

    
    
30. STEPANIAN A, Travers RJ, Tesfu A, Wolter NL, et al
    Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke.
    Circulation. 2025 Aug 5. doi: 10.1161/CIRCULATIONAHA.125.073610.
    

    >> Share

    
    July 2025
31. BELLOMO TR, Bramel EE, Lee J, Urbut S, et al
    Evaluation of Lipoprotein(a) as a Prognostic Marker of Extracoronary Atherosclerotic Vascular Disease Progression.
    Circulation. 2025 Jul 28:10.1161/CIRCULATIONAHA.124.073579.
    

    >> Share

    
    June 2025
32. MARTIN SS, Aday AW, Allen NB, Almarzooq ZI, et al
    Correction to: 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
    Circulation. 2025;151:e1096.
    

    >> Share

    
    
33. MARTIN SS, Aday AW, Almarzooq ZI, Anderson CAM, et al
    Correction to: 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
    Circulation. 2025;151:e1095.
    

    >> Share

    
    April 2025
34. CLARKE R, Wright N, Lin K, Yu C, et al
    Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study.
    Circulation. 2025 Apr 29. doi: 10.1161/CIRCULATIONAHA.124.072086.
    

    >> Share

    
    
35. LEE J, Balzraine B, Schweizer A, Kuzmanova V, et al
    Correction to: Neutrophil CRACR2A Promotes Neutrophil Recruitment in Sterile Inflammation and Ischemic Stroke.
    Circulation. 2025;151:e961.
    

    >> Share

    
    
36. SITTICHOKKANANON A, Garfield V, Chiesa ST
    Genetic and Lifestyle Risks for Coronary Artery Disease and Long-Term Risk of Incident Dementia Subtypes.
    Circulation. 2025 Apr 4. doi: 10.1161/CIRCULATIONAHA.124.070632.
    

    >> Share

    
    
37. VEKSTEIN AM, Wegermann ZK, Manandhar P, Mack MJ, et al
    Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the United States: A Report From the STS/ACC TVT Registry.
    Circulation. 2025 Apr 3. doi: 10.1161/CIRCULATIONAHA.124.071838.
    

    >> Share

    
    February 2025
38. KUEHN BM
    New Stroke Awareness Campaign Focuses on Hispanic and Latino People: Culturally Relevant and Spanish-Language Resources Aim to Improve Health Knowledge and Equity.
    Circulation. 2025;151:566-567.
    

    >> Share

    
    
39. 
    Correction to: Abstract 4139285: Awareness of Myocardial Infarction and Stroke Symptoms Among Asian American Adults: Insights from the National Health Interview Survey 2014 and 2017.
    Circulation. 2025;151:e681.
    

    >> Share

    
    
40. KANG J, Yoo JE, Jeon BJ, Im SI, et al
    Risk of Atrial Fibrillation After Hemorrhagic Stroke: A Nationwide Cohort Study With Propensity Score Matching.
    Circulation. 2025;151:331-333.
    

    >> Share

    
    January 2025
41. MARTIN SS, Aday AW, Allen NB, Almarzooq ZI, et al
    2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
    Circulation. 2025 Jan 27. doi: 10.1161/CIR.0000000000001303.
    

    >> Share

    
    
42. 
    Correction to: Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial.
    Circulation. 2025;151:e29.
    

    >> Share

    
    November 2024
43. LEE J, Balzraine B, Schweizer A, Kuzmanova V, et al
    Neutrophil CRACR2A Promotes Neutrophil Recruitment in Sterile Inflammation and Ischemic Stroke.
    Circulation. 2024 Nov 27. doi: 10.1161/CIRCULATIONAHA.124.070487.
    

    >> Share

    
    October 2024
44. ALDAAS OM, Aldaas AM, Hsu JC
    Letter by Aldaas et al Regarding Article, "Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials".
    Circulation. 2024;150:e273.
    

    >> Share

    
    
45. MCINTYRE WF, Benz AP, Healey JS, Lopes R, et al
    Response by McIntyre et al to Letter Regarding Article, "Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials".
    Circulation. 2024;150:e274-e275.
    

    >> Share

    
    September 2024
46. ROYAN R, Stamm B, Lin T, Baird J, et al
    Disparities in Emergency Medical Services Use, Prehospital Notification, and Symptom Onset to Arrival in Patients With Acute Stroke.
    Circulation. 2024 Sep 5. doi: 10.1161/CIRCULATIONAHA.124.070694.
    

    >> Share

    
    
47. MCINTYRE WF, Benz AP, Healey JS, Connolly SJ, et al
    Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial.
    Circulation. 2024 Sep 4. doi: 10.1161/CIRCULATIONAHA.124.069903.
    

    >> Share

    
    
48. MULDER MJHL, Cras TY, Shay J, Dippel DWJ, et al
    Comparison of American and European Guideline Recommendations for Diagnostic Workup and Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack.
    Circulation. 2024;150:806-815.
    

    >> Share

    
    
49. KEMP GUDMUNDSDOTTIR K, Svennberg E, Friberg L, Hygrell T, et al
    Randomized Invitation to Systematic NT-proBNP and ECG Screening in 75-Year Olds to Detect Atrial Fibrillation -STROKESTOP II.
    Circulation. 2024 Sep 1. doi: 10.1161/CIRCULATIONAHA.124.071176.
    

    >> Share

    
    August 2024
50. DELWARDE C, Aikawa M
    Novel Mouse Model of Late-Stage Coronary Atherosclerosis With Features of Plaque Rupture and Stroke.
    Circulation. 2024;150:706-709.
    

    >> Share

    
    
51. ZHAO D, Guallar E, Qiao Y, Knopman DS, et al
    Intracranial Atherosclerotic Disease and Incident Dementia: The ARIC Study (Atherosclerosis Risk in Communities).
    Circulation. 2024 Aug 1. doi: 10.1161/CIRCULATIONAHA.123.067003.
    

    >> Share

    
    July 2024
52. AULIN J, Sjolin K, Lindback J, Benz AP, et al
    Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation.
    Circulation. 2024 Jul 24. doi: 10.1161/CIRCULATIONAHA.124.069440.
    

    >> Share

    
    
53. 
    Correction to: Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial.
    Circulation. 2024;150:e20.
    

    >> Share

    
    June 2024
54. SHAMSUZZAMAN S, Deaton RA, Salamon A, Doviak H, et al
    Novel Mouse Model of Myocardial Infarction, Plaque Rupture, and Stroke Shows Improved Survival With Myeloperoxidase Inhibition.
    Circulation. 2024 Jun 17. doi: 10.1161/CIRCULATIONAHA.123.067931.
    

    >> Share

    
    
55. KAZI DS, Elkind MSV, Deutsch A, Dowd WN, et al
    Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association.
    Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001258.
    

    >> Share

    
    
56. JOYNT MADDOX KE, Elkind MSV, Aparicio HJ, Commodore-Mensah Y, et al
    Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050-Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association.
    Circulation. 2024 Jun 4. doi: 10.1161/CIR.0000000000001256.
    

    >> Share

    
    May 2024
57. ROHNER R, Kneihsl M, Goeldlin MB, Hakim A, et al
    Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized-controlled ELAN Trial.
    Circulation. 2024 May 16. doi: 10.1161/CIRCULATIONAHA.124.069324.
    

    >> Share

    
    
58. 
    Correction to: 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
    Circulation. 2024;149:e1164.
    

    >> Share

    
    
59. ELKIND MSV
    Stroke Science and Care Since the Founding of the American Heart Association.
    Circulation. 2024;149:1469-1470.
    

    >> Share

    
    April 2024
60. MAYER M
    Letter by Mayer Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants".
    Circulation. 2024;149:e1109-e1110.
    

    >> Share

    
    
61. ARMOUNDAS AA, Narayan SM, Arnett DK, Spector-Bagdady K, et al
    Use of Artificial Intelligence in Improving Outcomes in Heart Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2024;149:e1028-e1050.
    

    >> Share

    
    March 2024
62. PATEL SM, Ruff CT
    Subclinical Atrial Fibrillation and Anticoagulation: Weighing the Absolute Risks and Benefits.
    Circulation. 2024;149:989-992.
    

    >> Share

    
    
63. KHAN F, Coutts SB, Hill MD
    Letter by Khan et al Regarding Article, "Long-Term Incidence of Ischemic Stroke After Transient Ischemic Attack: A Nationwide Study from 2014 to 2020".
    Circulation. 2024;149:797-798.
    

    >> Share

    
    
64. VINDING NE, Fosbol EL
    Response by Vinding and Fosbol to Letter Regarding Article, "Long-Term Incidence of Ischemic Stroke After Transient Ischemic Attack: A Nationwide Study from 2014 to 2020".
    Circulation. 2024;149:799.
    

    >> Share

    
    February 2024
65. ELKIND MSV, Arnett DK, Benjamin IJ, Eckel RH, et al
    The American Heart Association at 100: A Century of Scientific Progress and the Future of Cardiovascular Science: A Presidential Advisory From the American Heart Association.
    Circulation. 2024 Feb 12. doi: 10.1161/CIR.0000000000001213.
    

    >> Share

    
    
66. GREEN JB, Everett BM, Ghosh A, Younes N, et al
    Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study).
    Circulation. 2024 Feb 12. doi: 10.1161/CIRCULATIONAHA.123.066604.
    

    >> Share

    
    January 2024
67. PATEL SM, Braunwald E, Steffel J, Boriani G, et al
    Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58 464 Patients With Atrial Fibr
    Circulation. 2024 Jan 24. doi: 10.1161/CIRCULATIONAHA.123.066279.
    

    >> Share

    
    December 2023
68. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    

    >> Share

    
    October 2023
69. KAPADIA SR, Krishnaswamy A, Whisenant B, Potluri S, et al
    Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients with Atrial Fibrillation.
    Circulation. 2023 Oct 24. doi: 10.1161/CIRCULATIONAHA.123.067312.
    

    >> Share

    
    
70. HOWARD G, Cushman M, Blair J, Wilson NR, et al
    Comparative Discrimination of Life's Simple 7 and Life's Essential 8 to Stratify Cardiovascular Risk: Is the Added Complexity Worth It?
    Circulation. 2023 Oct 13. doi: 10.1161/CIRCULATIONAHA.123.065472.
    

    >> Share

    
    September 2023
71. CONNOLLY SJ, Healey JS, Belley-Cote EP, Balasubramanian K, et al
    Oral Anticoagulation Use and Left Atrial Appendage Occlusion in LAAOS III.
    Circulation. 2023 Sep 21. doi: 10.1161/CIRCULATIONAHA.122.060315.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share